Aroxybutynin

Highest phase reached
Phase 2
www.ebi.ac.uk
Drug type
Small molecule
www.ebi.ac.uk

Listing at source
Listed
Highest phase reached
Phase 2
www.ebi.ac.uk

Drug type
Small molecule
www.ebi.ac.uk
Drug name
Aroxybutynin
www.ebi.ac.uk
Molecular weight
357.49
www.ebi.ac.uk
Structure (SMILES)
CCN(CC)CC#CCOC(=O)[C@](O)(c1ccccc1)C1CCCCC1
www.ebi.ac.uk

  • aroxybutynin component of ad 109
  • Aroxybutynin component of ad-109

  • (-)-oxybutynin
  • (r)-oxybutynin
  • ad 109 component aroxybutynin
  • AD-109 component Aroxybutynin
  • aroxybutynin
  • Aroxybutynin
  • aroxybutynin [INN]
  • aroxybutynin inn
  • aroxybutynina
  • Aroxybutynina
  • aroxybutynine
  • Aroxybutynine
  • oxybutynin
  • oxybutynin r
  • Oxybutynin, (-)-
  • Oxybutynin, (r)-
  • r oxybutynin
  • R-oxybutynin

ATC classification codes
  • G04BD04
Sources for recorded values
mor.nlm.nih.gov
CAS registry numbers
  • 119618-21-2
ChEMBL ID
CHEMBL185434
www.ebi.ac.uk
InChIKey
XIQVNETUBQGFHX-QFIPXVFZSA-N
www.ebi.ac.uk
PubChem compound IDs
  • 6098167
RxNorm IDs (RxCUI)
  • 32675
FDA ingredient codes (UNII)
  • 5BRQ29UUB7

First in class
No
Orphan designation
No

  • Condition identifier
    EFO_0003918
    Highest recorded phase
    3
  • Condition identifier
    MONDO_0007147
    Highest recorded phase
    3

Hydrogen bond acceptors
4
Hydrogen bond donors
1
Polar surface area
49.77
Calculated partition coefficient (ALogP)
3.34
Calculated partition coefficient (XLogP)
4.2
Prodrug
No
Chirality
Single enantiomer
Inorganic
No
Rule-of-five violations
0
Rotatable bonds
7
Heavy atoms
26
Molecular formula
C22H31NO3
Monoisotopic mass
357.23039385
Natural product
Yes

Recorded assays
3
Active assays
0

Cardiac potassium channel inhibition

Median
12,000
Mean
12,000
Minimum
12,000
Maximum
12,000
Unit
nM
Assays
1
Standard deviation
0
Summary method
median
Censored results excluded
0
Other units excluded
0
Unknown units excluded
0

Measurement types

  • IC50

Related records

Trials (2)

In development for (1)